February 5, 2015
TRACON Pharmaceuticals, Inc. has announced the pricing of its initial public offering of 3,600,000 shares of common stock at a price to the public of $10.00 per share. TRACON’s common stock began trading on The NASDAQ Global Market under the symbol “TCON” on January 30, 2015. The offering closed on February 4, 2015, subject to customary closing conditions. Latham & Watkins LLP represents the underwriters in the offering, with a corporate team led by partners Cheston Larson and Matthew Bush, with associates Christopher Geissinger and David Greer in San Diego.